Solid Tumors criteria

Related by string. * -SOLID . SOLID . SOLiD . SOLIS : Metal Gear Solid . Solid Waste Authority . Solid Waste Management . Rogelio V. Solis / TUMOR . tumors . TUMORS . tumor : malignant brain tumor . cancerous brain tumor . battling brain tumor . cancerous tumor removed / CRITERIA . criterias . Criteria : Common Criteria certification . Downgrade Criteria June . DSM IV criteria . Exclusion criteria * *

Related by context. Frequent words. (Click for all words.) 73 Solid Tumors 72 RECIST criteria 69 cytogenetic response 68 complete cytogenetic 67 mg kg dose 67 mucosal healing 67 RECIST 66 ACR# response 66 evaluable 65 plus dexamethasone 65 seroprotection 64 peripheral blood mononuclear 64 mycophenolate mofetil 64 undetectable HCV RNA 63 chlorambucil 63 patients evaluable 63 Epratuzumab 63 annualized relapse 63 Fludara 63 tumor lysis syndrome 63 sustained virologic response 63 plus methotrexate 63 DOXIL 62 complete remissions 62 evaluable patients 62 neoadjuvant chemotherapy 62 relapsed refractory multiple myeloma 62 Pegasys ® 62 Secondary endpoints include 62 nilotinib 62 bleomycin 62 peg IFN 62 heavily pretreated 62 HSCT 62 mg QD 61 estimated glomerular filtration 61 Amrubicin 61 Pivotal Phase III 61 Secondary endpoints 61 tolvaptan 61 DAS# [002] 61 Metastatic Colorectal Cancer 61 Jevtana 61 Thrombolysis 61 mRCC 61 achieved statistical significance 61 μg kg 61 mg BID 61 FOLFIRI 61 Disease Activity 61 Secondary endpoints included 61 azacitidine 61 Natalizumab 61 Bortezomib 60 plus prednisone 60 APOPTONE 60 surrogate endpoint 60 intravesical 60 glomerular filtration rate 60 TORISEL 60 hypomagnesemia 60 severe renal impairment 60 PREZISTA r 60 % CI #.#-#.# [003] 60 peginterferon alfa 2a 60 antibody titers 60 neoadjuvant therapy 60 #mg/day [001] 60 Metastatic Melanoma 60 serum phosphorus 60 composite endpoint 60 decitabine 59 virologic response 59 Phase III Clinical Trial 59 PROMACTA 59 dasatinib 59 mcg dose 59 tocilizumab 59 ACR# [002] 59 irbesartan 59 adalimumab 59 interferon alfa 59 neoadjuvant 59 Pharmacokinetic 59 noninferiority 59 creatinine clearance 59 Chronic Hepatitis C 59 Monotherapy 59 interferon therapy 59 Relapsed 59 daunorubicin 59 HER2 positive metastatic breast 59 J Am Coll 59 FLT3 59 Irinotecan 59 eniluracil 59 Lenalidomide 59 cabazitaxel 59 anakinra 59 CYP#C# [002] 59 serum concentrations

Back to home page